Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1997 3
2001 2
2002 4
2003 4
2004 3
2005 10
2006 5
2007 2
2008 4
2009 8
2010 3
2011 4
2012 6
2013 5
2014 9
2015 4
2016 8
2017 7
2018 8
2019 2
2020 6
2021 1
2022 3
2023 1
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

106 results

Results by year

Filters applied: . Clear all
Page 1
Ocrelizumab versus Interferon Beta-1a in Relapsing Multiple Sclerosis.
Hauser SL, Bar-Or A, Comi G, Giovannoni G, Hartung HP, Hemmer B, Lublin F, Montalban X, Rammohan KW, Selmaj K, Traboulsee A, Wolinsky JS, Arnold DL, Klingelschmitt G, Masterman D, Fontoura P, Belachew S, Chin P, Mairon N, Garren H, Kappos L; OPERA I and OPERA II Clinical Investigators. Hauser SL, et al. N Engl J Med. 2017 Jan 19;376(3):221-234. doi: 10.1056/NEJMoa1601277. Epub 2016 Dec 21. N Engl J Med. 2017. PMID: 28002679 Free article. Clinical Trial.
Two Phase 3 Trials of Gantenerumab in Early Alzheimer's Disease.
Bateman RJ, Smith J, Donohue MC, Delmar P, Abbas R, Salloway S, Wojtowicz J, Blennow K, Bittner T, Black SE, Klein G, Boada M, Grimmer T, Tamaoka A, Perry RJ, Turner RS, Watson D, Woodward M, Thanasopoulou A, Lane C, Baudler M, Fox NC, Cummings JL, Fontoura P, Doody RS; GRADUATE I and II Investigators and the Gantenerumab Study Group. Bateman RJ, et al. N Engl J Med. 2023 Nov 16;389(20):1862-1876. doi: 10.1056/NEJMoa2304430. N Engl J Med. 2023. PMID: 37966285 Clinical Trial.
Biofuels from microbes.
Antoni D, Zverlov VV, Schwarz WH. Antoni D, et al. Among authors: schwarz wh. Appl Microbiol Biotechnol. 2007 Nov;77(1):23-35. doi: 10.1007/s00253-007-1163-x. Epub 2007 Sep 22. Appl Microbiol Biotechnol. 2007. PMID: 17891391 Review.
Genomics of cellulolytic bacteria.
Koeck DE, Pechtl A, Zverlov VV, Schwarz WH. Koeck DE, et al. Among authors: schwarz wh. Curr Opin Biotechnol. 2014 Oct;29:171-83. doi: 10.1016/j.copbio.2014.07.002. Epub 2014 Aug 5. Curr Opin Biotechnol. 2014. PMID: 25104562 Review.
Xanthan: enzymatic degradation and novel perspectives of applications.
Berezina OV, Rykov SV, Schwarz WH, Liebl W. Berezina OV, et al. Among authors: schwarz wh. Appl Microbiol Biotechnol. 2024 Feb 21;108(1):227. doi: 10.1007/s00253-024-13016-6. Appl Microbiol Biotechnol. 2024. PMID: 38381223 Free PMC article. Review.
Extracellular glycosyl hydrolases from clostridia.
Schwarz WH, Zverlov VV, Bahl H. Schwarz WH, et al. Adv Appl Microbiol. 2004;56:215-61. doi: 10.1016/S0065-2164(04)56007-0. Adv Appl Microbiol. 2004. PMID: 15566981 Review. No abstract available.
4'-phosphopantetheine biosynthesis in Archaea.
Kupke T, Schwarz W. Kupke T, et al. Among authors: schwarz w. J Biol Chem. 2006 Mar 3;281(9):5435-44. doi: 10.1074/jbc.M510056200. Epub 2005 Dec 21. J Biol Chem. 2006. PMID: 16371361 Free article.
106 results